Inari Medical, Inc. (NARI) Tops Q4 EPS by 6c

Inari Medical, Inc. (NASDAQ: NARI) reported Q4 EPS of ($0.11), $0.06 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $107.8 million versus the consensus estimate of $103.78 million.

For earnings history and earnings-related data on Inari Medical, Inc. (NARI) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters
• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat